irinotecan has been researched along with Aneuploid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berman, J; Bradford, WD; Chen, G; Conkright, J; Haug, JS; Kucharavy, A; Li, R; McCroskey, S; Mulla, WA; Rubinstein, B; Seidel, CW; Tsai, HJ; Weems, L | 1 |
| Brünner, N; Guo, J; Huang, X; Li, L; Liu, S; Pan, Q; Ren, Y; Ren, Z; Stenvang, J; Wen, B; Wu, L; Xu, S; Zhang, C; Zhou, R; Zi, J | 1 |
2 other study(ies) available for irinotecan and Aneuploid
| Article | Year |
|---|---|
Targeting the adaptability of heterogeneous aneuploids.
Topics: Aneuploidy; Antifungal Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Candida albicans; Cell Line, Tumor; Drug Resistance, Fungal; Drug Resistance, Neoplasm; ErbB Receptors; Fluconazole; Glioblastoma; Humans; Hygromycin B; Irinotecan; Saccharomyces cerevisiae | 2015 |
Drug Resistance in Colorectal Cancer Cell Lines is Partially Associated with Aneuploidy Status in Light of Profiling Gene Expression.
Topics: Aneuploidy; Camptothecin; Cell Line, Tumor; Chromosomes, Human, Pair 14; Colorectal Neoplasms; Drug Resistance; Gene Dosage; Gene Expression Profiling; HCT116 Cells; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin | 2016 |